At Reid 2017 we interviewed Jennifer Hincks, Principal Scientist at LGC, about her role in setting up a new flow cytometry service. Jennifer discusses her passion for flow cytometry, how it can be used to analyze biomarkers and how this field can be regulated and standardized.
We talk to John Lough, University of Sunderland, who discusses how to prepare graduates to become drug bioanalysts.
At Reid 2017 we interviewed James Rudge, Global Microsampling Specialist at Neoteryx, about his role in developing volumetric absorptive microsampling. James talks about his interest in biomarkers, what technologies he uses to analyze biomarkers and how he thinks the ‘omics’ field will come online.
We talk to Jiangjiang (Chris) Zhu about his career, emerging technologies and MS-based metabolomics as a focus for his recent work.
In this installment of Robert MacNeill’s (Envigo) column, Robert discusses the instability of drugs within samples and how to balance their instability against absorptive loss.
Over the past 7 years, Bioanalysis Zone have supported and recognized outstanding early-career researchers in the field of bioanalysis. We followed up with all our previous nominees to discover where they are now and discuss the impact of being nominated for the award.
2. Given the complexity and cost of development and manufacturing, are biosimilars more affordable therapeutic options?
In this ‘Ask the Experts’ feature, the experts discuss the complexity and cost of development and whether biosimilars are more affordable therapeutic options.
In this ‘Ask the Experts’ feature we will be discussing what is required to gain approval for a biosimilar.
In this ‘Ask the Experts’ feature we will be discussing the use of biosimilars with a number of leading experts across the field. The series will explore the role of biosimilars, address the benefits and challenges of creating them and how they have gained momentum within the pharmaceutical industry.
Ask the Experts: Arno Kromminga